Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase NA 2Phase 4 2

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vomiting 3Postoperative Nausea and Vomiting 1Ovarian Neoplasms 1Neoplasms 1Myofibroma 1Adenomyosis 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Interventional × ramosetron × Clear all
NCT02011659 2013-12-13

PONV

National Health Insurance Service Ilsan Hospital

Phase 3 Unknown
128 enrolled
Gynecologic

Ovarian Neoplasms, Vomiting, Postoperative Nausea and Vomiting, Myofibroma, Adenomyosis

NCT01536691 2012-10-03

ROAD

Hallym University Medical Center

Phase 3 Unknown
338 enrolled

Neoplasms, Vomiting

NCT00971399 2011-02-28

Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting

Seoul National University Hospital

Phase 3 Completed
172 enrolled

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡